Related Experiment Video
Updated: Jul 28, 2026

07:18
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019
Distinct MDM2 and P14ARF expression and centrosome amplification in well-differentiated liposarcomas
D Perucca-Lostanlen1, P Rostagno, J Grosgeorge
1UMR 6549 CNRS/UNSA, Faculté de Médecine, Avenue de Valombrose, Nice, France. perucca@unice.fr
Genes, Chromosomes & Cancer
|December 30, 2003
Summary
Well-differentiated liposarcomas (WDLs) show distinct protein expression profiles based on cell ploidy. Centrosome amplification occurs in both WDL subtypes, irrespective of their karyotype.
Area of Science:
- Oncology
- Genetics
- Cell Biology
Background:
- Well-differentiated liposarcomas (WDLs) are common adult soft-tissue tumors.
- WDLs are characterized by amplified 12q-derived sequences, particularly MDM2.
- WDLs are classified into Type D (near-diploid) and Type H (near-tetraploid) based on karyotype.
Purpose of the Study:
- To investigate protein expression profiles (P14ARF, MDM2, TP53) in WDL subtypes.
- To determine if protein expression correlates with cell ploidy.
- To examine centrosome behavior in relation to WDL subtypes and ploidy.
Main Methods:
- Karyotyping to classify WDL subtypes (Type D and Type H).
- Assaying expression of P14ARF, MDM2, and TP53 proteins.
- Investigating centrosome behavior in WDL cells.
Main Results:
- Type H cells showed high P14ARF and MDM2 protein levels, unlike Type D.
- TP53 was transcriptionally functional in most tumors, regardless of karyotype.
- MDM2 was not overexpressed in Type D tumors and showed alternative splicing.
- Centrosome amplification was observed in both Type H and Type D WDLs, independent of ploidy.
Conclusions:
- Distinct WDL subtypes exhibit differential protein expression patterns.
- Centrosome amplification is a common feature in WDLs, irrespective of karyotype.
- Further research into MDM2 alternative splicing in WDLs is warranted.

